NRC Health (NRC) Debt / Equity
- 2026-06-30: Debt/Equity Ratio 13.75.
- 2025-12-31: Debt/Equity Ratio 5.65.
- 2017-12-31: Debt/Equity Ratio 0.02.
- 2016-12-31: Debt/Equity Ratio 0.04.
Complete source-backed debt/equity ratio history.
- Available history
- 2012-12-31 to 2026-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2026-06-30 | 13.75 |
| 2025-12-31 | 5.65 |
| 2017-12-31 | 0.02 |
| 2016-12-31 | 0.04 |
| 2015-12-31 | 0.08 |
| 2014-12-31 | 0.09 |
| 2013-12-31 | 0.14 |
| 2012-12-31 | 0.44 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2017-12-31 | 0.02 |
| 2016-12-31 | 0.04 |
| 2015-12-31 | 0.08 |
| 2014-12-31 | 0.09 |
| 2013-12-31 | 0.14 |
| 2012-12-31 | 0.44 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |